A 52-year-old patient sat across from me last week and said, "I don't even think about sex anymore. And I'm not sure if that bothers me, or if the fact that it doesn't bother me is what bothers me." That sentence captures something I hear constantly in this practice. Loss of libido in mid-life is rarely just about sex. It is about the loss of a part of yourself you assumed would always be there, and the quiet realization that nobody — not your primary care doctor, not your gynecologist, not your urologist — has actually asked you about it in a meaningful way in years.
I want to walk through what I look for when a patient brings this up, because the honest answer is that libido sits at an intersection of hormones, vasculature, neurology, medication, and psychology — and the workup that finds the actual driver is the workup that produces a real result. Single-variable approaches almost always disappoint.
Why "low libido" is the wrong question to start with
When a patient tells me their libido is gone, the first thing I want to know is what specifically has changed. Libido is not one thing. It is a stack of related but distinct functions: spontaneous desire (do you think about sex unprompted), responsive desire (does desire emerge in response to a partner or context), arousal (does the body respond when you want it to), function (does the body do what arousal asks of it), and satisfaction (is the experience itself rewarding). Each of these has different physiological drivers. Each can fail independently.
A 48-year-old woman who has lost spontaneous desire but still enjoys sex when it happens is dealing with a different problem than a 48-year-old man who wants sex but cannot maintain an erection. The conversation has to surface which functions have shifted before any intervention can be matched to the actual deficit. I see clinicians skip this step constantly. The result is testosterone prescribed when the issue is vascular, ED treatment prescribed when the issue is hormonal, and SSRIs continued when they are the proximal cause of the dysfunction.
The mechanism — what hormones actually do to sexual function
The relevant hormones interact at multiple sites, and understanding the mechanism makes the treatment plan make sense.
Testosterone in both sexes. Testosterone is the primary driver of libido in men and a significant contributor in women. It acts centrally on the dopaminergic reward circuits in the brain that generate sexual desire, and peripherally on tissue sensitivity. In men, free testosterone — not just total — is what matters; SHBG can bind enough testosterone that the bioavailable fraction is functionally low even when the total looks adequate. In women, ovaries and adrenals produce small amounts of testosterone, and its decline through perimenopause is a meaningful contributor to libido loss that often gets attributed entirely to estrogen.
Estrogen in women. Estradiol maintains the vaginal and urethral tissue, supports lubrication, and sustains the genital vascular response. When estrogen drops in perimenopause and menopause, the tissue thins (genitourinary syndrome of menopause), lubrication fails, and intercourse becomes uncomfortable. The brain learns from that experience. Desire drops not because the desire circuitry has failed, but because the body has been telling the brain that sex is uncomfortable for years.
Progesterone in women. Progesterone is rarely discussed in libido conversations but matters for sleep and mood. A patient who is not sleeping and is anxious is not going to feel desire regardless of where her testosterone sits.
Cortisol and prolactin. Chronically elevated cortisol suppresses sex hormones and reduces libido directly. Elevated prolactin — sometimes from medications, sometimes from a pituitary process — suppresses gonadal function. I check both in the right clinical context.
Vascular and endothelial health. Erections are a vascular event. So is genital arousal in women. When the small vessels are not responding well — early atherosclerosis, endothelial dysfunction, untreated hypertension, untreated insulin resistance — the hormonal substrate may be intact but the plumbing fails. This is one reason that erectile dysfunction in a man under 55 deserves a cardiac workup, not just a prescription. From 17 years in emergency medicine, cardiac ICU, and the cath lab, I will tell you plainly: ED is sometimes the first sign of vascular disease, and it should be treated as the cardiac warning it is until proven otherwise.
What I look for on the panel
When I evaluate someone for libido or sexual function concerns, the panel I run is broader than what most patients arrive with:
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
- Total and free testosterone, plus SHBG (so I can calculate bioavailable testosterone correctly)
- Estradiol — in both sexes, because aromatization of testosterone to estradiol matters
- Progesterone in cycling and perimenopausal women
- DHEA-S
- Full thyroid panel including free T3, free T4, reverse T3, and antibodies
- Prolactin
- Fasting insulin, HbA1c, and a lipid panel — vascular substrate
- hs-CRP for inflammation
- Vitamin D, ferritin, B12, magnesium
- Pelvic exam for women when the history suggests genitourinary syndrome
I also do a careful medication review. SSRIs are the single most common medication-related cause of sexual dysfunction in this practice. Beta-blockers, finasteride, antihistamines, PPIs, opioids, and certain antiseizure medications all show up. Sometimes the most effective intervention is working with the prescribing provider to swap a medication, not adding a new one.
How treatment actually gets built
Once the data is in hand, the plan is built around what the data shows. A few common patterns:
Perimenopausal woman with low estradiol, low free testosterone, sleep disruption, and vaginal dryness. Plan: hormone optimization with bioidentical estradiol and progesterone, low-dose testosterone if the free testosterone is documented low and symptoms warrant it, vaginal estrogen for the genitourinary symptoms specifically. Re-test at 8 to 12 weeks. Most of these patients report meaningful libido recovery by month 3 — but it is the recovery of the substrate (sleep, comfort, energy, tissue health) that drives the libido, not a "libido medication."
Man in his 50s with free testosterone in the bottom quartile, central adiposity, fatigue, and erectile difficulty. Plan: confirm with a second draw, check hematocrit and PSA at baseline, evaluate cardiovascular risk before initiating. If men's hormone therapy is appropriate, start conservatively. Address the metabolic picture in parallel, because testosterone in a metabolically unhealthy patient is suboptimal therapy. If vascular contribution is significant, that gets worked up separately.
Woman with intact hormones, normal labs, and persistent loss of arousal and tissue responsiveness. Plan: regenerative options like the O-Shot become reasonable to discuss. PRP-based interventions can produce meaningful change in tissue quality and responsiveness in a subset of patients. I am candid about the evidence — it is not a guaranteed result, but in the right candidate the response can be substantial. The procedure is well-tolerated and recovery is mild.
Patient on an SSRI with sexual side effects. Plan: a real conversation with the prescriber about whether the underlying mood disorder is in remission and whether a swap to a less sexually-suppressive agent is reasonable. Sometimes the most useful thing I can do is write a letter to the patient's psychiatrist.
What realistic results look like
Hormonal interventions usually produce the first noticeable shift between weeks 2 and 4, with continued improvement through months 3 to 6 as the body adapts and sleep, mood, and tissue health all improve in parallel. Regenerative treatments work over 8 to 12 weeks. Vascular interventions — when ED has a vascular component — are slower and more dependent on systemic risk-factor modification.
The patients who do best are the ones who treat this as a multi-system problem rather than a single-pill problem. The ones who chase a single intervention and ignore the adjacent factors usually plateau and get frustrated.
Concrete next step
If sexual function or libido is something you have been carrying privately for a while, the useful next step is a comprehensive workup and a private consultation. Bring whatever lab work you have, a complete medication and supplement list, and the specific functions that have changed — desire, arousal, function, satisfaction. The conversation is private, the documentation is held to the same standard as any other medical record, and the goal is to actually solve the problem, not to manage it.
*Information in this article is educational and does not constitute medical advice. Consultation and lab work are required before any treatment is recommended. Individual results vary.*
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.